The role of Cochrane reviews in informing international guidelines: A case study of using the grading of recommendations, assessment, development and evaluation system to develop World Health Organization guidelines for the psychosocially assisted pharmacological treatment of opioid dependence

Addiction

Volumn 110, Issue 6, 2015, Pages 891-898

  Davoli, Marina ^a   Amato, Laura ^a   Clark, Nicolas ^b   Farrell, Michael ^c   Hickman, Matthew ^d   Hill, Suzanne ^e   Magrini, Nicola ^f   Poznyak, Vladimir ^b   Schünemann, Holger J ^g  

^a DEPARTMENT OF EPIDEMIOLOGY   (Italy)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d UNIVERSITY OF BRISTOL   (United Kingdom)

^e UNIVERSITY OF MELBOURNE   (Australia)

^f Agency for Health Care and Social Services of Emilia Romagna   (Italy)

^g MCMASTER UNIVERSITY   (Canada)

Author keywords

Cochrane reviews; GRADE methodology; Opiate related disorders; Substance abuse treatments; WHO guidelines

Indexed keywords

NARCOTIC ANTAGONIST;

EVIDENCE BASED MEDICINE; HUMAN; LITERATURE; MULTIMODALITY CANCER THERAPY; OPIOID-RELATED DISORDERS; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SOCIAL SUPPORT; WORLD HEALTH ORGANIZATION;

COMBINED MODALITY THERAPY; EVIDENCE-BASED MEDICINE; HUMANS; NARCOTIC ANTAGONISTS; OPIOID-RELATED DISORDERS; PRACTICE GUIDELINES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REVIEW LITERATURE AS TOPIC; SOCIAL SUPPORT; WORLD HEALTH ORGANIZATION;

EID: 84929081444     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/add.12788     Document Type: Article

References (26)

1. Economic and Social Council. 2014. ECOSOC resolution 2004/40. Available at: http://www.un.org/docs/ecosoc/documents/2004/resolutions/eres2004-40.pdf (accessed 15 March 2013) (Archived at http://www.webcitation.org/6UAlgr1jK on 18 November 2014).
2. Oxman A. D., Lavis J. N., Fretheim A. Use of evidence in WHO recommendations. Lancet 2007; 369: 1883-1889.
3. McCarthy M. Critics slam draft WHO report on homoeopathy. Lancet 2005; 366: 705-706.
4. Horton R. WHO: the casualties and compromises of renewal. Lancet 2002; 359: 1605-1611.
5. Bradbury J. Storm over WHO-ISH hypertension guidelines. Lancet 1999; 353: 563.
6. Hill S., Pang T. Leading by example: a culture change at WHO. Lancet 2007; 369: 1842-1844.
7. World Health Organization (WHO). 2012 WHO Handbook for guideline development. Available at: http://apps.who.int/iris/bitstream/10665/75146/1/9789241548441_eng.pdf (accessed 24 April 2013) (Archived at http://www.webcitation.org/6UAkngUiu on 18 November 2014).
8. Guyatt G. H., Oxman A. D., Vist G. E., Kunz R., Falck-Ytter Y., Alonso-Coello P. etal. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008; 336: 924-926.
9. Oxman A. D., Fretheim A., Schunemann H. J. Improving the use of research evidence in guideline development: introduction. Health Res Policy Syst 2006; 4: 12.
10. Guyatt G., Oxman A. D., Akl E. A., Kunz R., Vist G., Brozek J. etal. GRADE guidelines 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol 2011; 64: 383-394.
11. Atkins D., Best D., Briss P. A., Eccles M., Falck-Ytter Y., Flottorp S. etal. for the GRADE Working Group. Grading quality of evidence and strength of recommendations. BMJ 2004; 328: 1490-1494.
12. Schunemann H. J., Hill S. R., Kakad M., Vist G. E., Bellamy R. etal. Transparent development of the WHO rapid advice guidelines. PLOS Med 2007; 4: e11. doi: 10.1371/journal.pmed.0040119.
13. Schunemann H. J., Hill S. R., Kakad M., Bellamy R., Uyeki T. M. etal. WHO Rapid Advice Guidelines for pharmacological management of sporadic human infection with avian influenza A (H5N1) virus. Lancet Infect Dis 2007; 7: 21-31.
14. World Health Organization (WHO). Guidelines for the Psychosocially Assisted Pharmacological Treatment of Opioid Dependence. Geneva: WHO; 2009.
15. Guyatt G. H., Oxman A. D., Kunz R., Vist G. E., Falck-Ytter Y., Schünemann H. J. What is 'quality of evidence' and why is it important to clinicians? BMJ 2008; 336: 995-998.
16. Brozek J. L., Akl E. A., Alonso-Coello P., Lang D., Jaeschke R., Williams J. W. etal. for the GRADE Working Group. Grading quality of evidence and strength of recommendations in clinical practice guidelines. Part 1 of 3. An overview of the GRADE approach and grading quality of evidence about interventions. Allergy 2009; 64: 669-677.
17. Mattick R. P., Breen C., Kimber J., Davoli M. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev 2009; 3. CD002209. doi: 10.1002/14651858.
18. National Institute for Health and Care Excellence (NICE). National Institute of Clinical Excellence Technology Appraisal Guidance 114. 2006. Methadone and buprenorphine for the management of opioid dependence. Available at: http://www.nice.org.uk (accessed 15 March 2013) (Archived at http://www.webcitation.org/6UAku4Kpg on 18 Novembre 2014).
19. Bargagli A., Davoli M., Minozzi S., Vecchi S., Perucci C. A Systematic Review of Observational Studies on Treatment of Opioid Dependence. 2007. Geneva, Switzerland, background document prepared for third meeting of Technical Development Group (TDG) for the WHO Guidelines for Psychosocially Assisted Pharmacotherapy of Opiod Dependence, 17-21 September. Available at: http://www.who.int/substance:abuse/activities/observational_studies_treatment.pdf (accessed 15 March 2013) (Archived at http://www.webcitation.org/6UAlzqZJT on 18 November 2014).
20. Mattick R. P., Kimber J., Breen C., Davoli M. Buprenorphinemaintenance versus placebo ormethadonemaintenance for opioid dependence. Cochrane Database Syst Rev 2008; 2. CD002207. doi: 10.1002/14651858.
21. Minozzi S., Amato L., Vecchi S., Davoli M., Kirchmayer U., Verster A. Oral naltrexone maintenance treatment for opioid dependence. Cochrane Database Syst Rev 2011; 4. CD001333. doi: 10.1002/14651858.
22. Faggiano F., Vigna-Taglianti F., Versino E., Lemma P. Methadone maintenance at different dosages for opioid dependence. Cochrane Database Syst Rev 2003; 3. CD002208.
23. Swiglo B. A., Murad M. H., Schunemann H. J., Kunz R., Vigersky R. A., Guyatt G. H. etal. A case for clarity, consistency, and helpfulness: state-of-the-art clinical practice guidelines in endocrinology using the grading of recommendations, assessment, development, and evaluation system. J Clin Endocrinol Metab 2008; 93: 666-673.
24. Gowing L., Ali R., White J. M. Opioid antagonists under heavy sedation or anaesthesia for opioid withdrawal. Cochrane Database Syst Rev 2010; 1. CD002022. doi: 10.1002/14651858.
25. Gowing L., Ali R., White J. M. Opioid antagonists with minimal sedation for opioid withdrawal. Cochrane Database Syst Rev 2009; 4. CD002021. doi: 10.1002/14651858.
26. Treweek S., Oxman A. D., Alderson P., Bossuyt P. M., Brandt L., Brozek J. etal. for the DECIDE Consortium. Developing and evaluating communication strategies to support informed decisions and practice based on evidence (DECIDE): protocol and preliminary results. Implement Sci 2013; 8: 6.